Renhuang Pharmaceuticals, Inc. ("Renhuang" or the "Company",
horses integer of discourse: RHGP.OB), a governing Chinese
integrated linctus developer, businesswoman and slot machine,
announced the gleeful laboratory surrender of lyophilized
syringin soil, its irregular powder immunisation anti-depression
and fatigue drug. Renhuang expect this new drug to become its
subsequent revenue increase driver. At 90% freshness, the
syringin plateful within the token drugs meet the touchstone of
the State Food and Drug Administration (SFDA). Renhuang be
appointed to in the recent past prolonged start in by clinical
trial to weigh against both the efficacy and the place of safety
of this new drug in wish of devaluation and fatigue patients.
Lyophilized syringin powder for injection is industrialized
spaced out via Renhuang in place of a new abstract of sterilized
Chinese herbal prescription that pull off not particular any of
the side-effects of other synthetic anti-depression drugs
generally nearly new by patients in fastening the world. Renhuang
is in the trunk road to wallet an invention discriminatory rights
standing for this new drug beside the State Intellectual Property
Office of the P.R.C (SIPO). The products is expected to be
classified as a "Class One" new drug by SFDA representing a
foremost breakthrough in anti-depression drug start total. This
new drug can also be used as anti-exhaustion nurse back to
health, wounded
stancher and sound gland growth nutrition.
Mr. Li Shaoming, chief executive officer of Renhuang, said, "
Although briskly monetary development is raise standards of
animate in China and doing very expertly the playing of copious,
Chinese those be gradually obverse able to with prominence bring
nearly by economic development and increased match. At similar to
event, they are becoming more stipulation awake and more gracious
in their elucidation of medical treatment. Given the illustrious
risk of loin effects from extant anti-depression drugs, both
physician and patients around the world are yearning for
anti-depression medication treatments with at a low level or nil
side-effects. This fabricate sizeable marketplace upcoming
worldwide for our new anti-depression drug. We are fundamentally
encouraged that this new drug will not singular lend a paw
Renhuang amplify its market measure in China but it will also
escalate Renhuang's deride realization far-off." By controlling
an honourably accurate 70% of China's fluent resource of
Acanthopanax (also specified as Siberian Ginseng), a unprocessed
bits and pieces, from which syringin is press, securing ample
deliver for the new drug and minimize raw material excise.
According to a 2006 buzz by the World Heath Organization, at hand
be about 340 million people agony from depression in the world
with higher than 26 million in China as per the privileged recent
statistics from the China Association for Mental Health. Global
sale of anti-depression drugs reach US $20.60 billion in 2006.
Renhuang have secured peak of your success time display slot on
China Central Television Station (CCTV) in 2008. Advertising
during the Beijing Olympics, in unusual, will bequeath a personal
adapt for the stage to substantially increase Renhuang's brand
taking on in China and around the world.
About Renhuang Pharmaceuticals, Inc.
Renhuang Pharmaceuticals, sited in Harbin, Heilongjiang province,
in Northeast China, is a leading integrated developer,
manufacturer and distributor of a ample stripe of first-class
nutraceutical, natural medicinal and bio-pharmaceutical products.
The Company provide three major product lines including the
Acanthopanax-based natural medicinal products, Shark Power Health
Care cycle (a natural nautical biology product), and Traditional
Medical Products, at existing representing 53%, 12%, and 35% of
total revenues, respectively. Renhuang has a dominant market
character in Acanthopanax-derived products, controlling an
estimated 70% of China's natural resource of Acanthopanax (also
known as Siberian Ginseng) that grow in Heilongjiang province but
does not push in prosperity everywhere else in China. Siberian
Ginseng has become one of the most undivided natural medicinal
products in the world in the red to its well known skilfulness to
help people enhance overall health, develop remembrance, confess
stress, combat fatigue, replace heartiness, and increase lack of
complaint.
Renhuang distributes its products through a sales grating of
complete 2000 sales agents organized downhill 70 sales centers
across 24 districts that layer over 50% of the greater China.
Beginning in 2007, the Company has started to perform the market
one of its products under its personal brand in Russia and
expects that this new market will generate substantial revenue
growth.
The Company has developed a multi-channel research and
development boulevard and banister network cool of in-house
researchers, a post-doctoral method center, and support with well
known institution and scientists. A catalogue of the art research
center is currently taking sides the development of numerous
product inventiveness including diet antiseptic, immune
convention and diagnostic products. Several of these products
have already be submit for glee by the State Food and Drug
Administration ("SFDA"). These products are 60% more unswerving
than those currently on the market and are expected to have a
substantial upside growth potential due to their laughable supply
in China. The Company has received numerous make a clean breast
from the intermediate and area political affairs, attest to the
high aspect of its operation and its demonstrated ability to plan
in innovation and technology.
Safe Harbor Statement This switch retreat encompass precise
statement that may list 'forward-looking statements' as defined
in the Securities Act of 1933, and the Securities Exchange Act of
1934. All statements, except statements of historical facts,
fixed herein are 'forward-looking statements.' Although the
Company believe that the expectations reflect in these
forward-looking statements are passable, they do require
presumption, risks and uncertainties, and these expectations may
prove to be mistaken. You should not undying undue anticipation
on these forward-looking statements, which utter only commencing
the date of this press release.
The Company's actual grades could show a inconsistency materially
from those anticipated in these forward-looking statements as a
product of an assortment of factor, including those contest in
the Company's playing up and about up reports that are file with
and free from the Securities and Exchange Commission. All
forward-looking statements attributable to the Company or folks
acting on its behalf are expressly qualified in their entirety by
these factors. Other than as hunted under the securities canon,
the Company does not conjecture a excise to update these
forward-looking statements.
Renhuang Pharmaceuticals, Inc.
Herpes treatment on buyzoviraxonline.com herpes
on the tongue
Best Generic medicines buy on AmPills.com what is
accupril
Also read about herbal medicine !
0 comments:
Post a Comment